申请人:Sankyo Company, Limited
公开号:EP1783216A1
公开(公告)日:2007-05-09
A compound represented by general formula:
E1-B1-B2-B3-B4-E2 (I)
(wherein E1 represents a group represented by the formula R1- or the like; E2 represents a group represented by the formula -B7-R2 or the like; B4, B5, and B8 are identical or different, and each represents Tp or the like; B1, B2, B3, and B12 are identical or different, and each represents Gp or the like; B 16 represents Cp or the like; and B6, B10, B14, and B18 are identical or different, and each represents Ap or the like) or a pharmacologically acceptable salt thereof, inhibits the action of telomerase and is effective in treating diseases in which telomerase is involved.
由通式代表的化合物:
E1-B1-B2-B3-B4-E2 (I)
(其中 E1 代表由式 R1-或类似物代表的基团;E2 代表由式 -B7-R2 或类似物代表的基团;B4、B5 和 B8 相同或不同,且各自代表 Tp 或类似物;B1、B2、B3 和 B12 相同或不同,且各自代表 Gp 或类似物;B16代表Cp或类似物;以及B6、B10、B14和B18相同或不同,且各自代表Ap或类似物)或其药理学上可接受的盐,可抑制端粒酶的作用,对治疗端粒酶参与的疾病有效。